Recent Advances in Targeted Radionuclide Therapy of Cancers:@0.319158:0.035749:0.914575:0.035749:0.914575:0.019993:0.319158:0.019993:0.011680:0.012508:0.012450:0.012508:0.011738:0.006523:0.005330:0.014239:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.007466:0.005330:0.003848:0.011738:0.005330:0.007179:0.013143:0.005809:0.012950:0.012508:0.006523:0.012508:0.013181:0.005330:0.011680:0.013143:0.013181:0.003848:0.012604:0.011738:0.011699:0.012450:0.003848:0.003848:0.013181:0.012508:0.005330:0.008197:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.012604:0.006042:0.005330:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
25:@0.955522:0.038184:0.976595:0.038184:0.976595:0.018587:0.955522:0.018587:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
PEPTIDE RECEPTOR RADIONUCLIDE :@0.084242:0.447439:0.470886:0.447439:0.470886:0.427842:0.084242:0.427842:0.013170:0.012230:0.013170:0.009878:0.006585:0.016463:0.012230:0.006585:0.013641:0.012230:0.018344:0.012230:0.013170:0.009878:0.019756:0.013641:0.006585:0.013641:0.017404:0.016463:0.006585:0.019756:0.017404:0.015052:0.018344:0.010348:0.006585:0.016463:0.012230:0.006585
THERAPY OF NEURO-ENDOCRINE :@0.084242:0.467100:0.453953:0.467100:0.453953:0.447503:0.084242:0.447503:0.009878:0.015993:0.012230:0.013641:0.017404:0.013170:0.014581:0.006585:0.019756:0.011289:0.006585:0.017404:0.012230:0.015052:0.013641:0.019756:0.009878:0.012230:0.017404:0.016463:0.019756:0.018344:0.013641:0.006585:0.017404:0.012230:0.006585
TUMOURS:@0.084242:0.486762:0.191016:0.486762:0.191016:0.467165:0.084242:0.467165:0.009878:0.015052:0.021167:0.019756:0.015052:0.013641:0.012230
Neuro-endocrine  tumours  (NETs) are a :@0.084242:0.501378:0.480480:0.501378:0.480480:0.485622:0.084242:0.485622:0.014239:0.012508:0.011699:0.005703:0.012604:0.006388:0.012508:0.011738:0.013181:0.012604:0.012450:0.005792:0.003848:0.011738:0.012508:0.005330:0.009431:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.009436:0.007100:0.014239:0.010314:0.007755:0.007466:0.007100:0.014778:0.013143:0.005715:0.012508:0.014778:0.013143:0.005330
heterogeneous  group  of  tumours  that :@0.084242:0.518100:0.480492:0.518100:0.480492:0.502344:0.084242:0.502344:0.011738:0.012508:0.006523:0.012508:0.005703:0.012604:0.012950:0.012508:0.011738:0.012508:0.012604:0.011699:0.007466:0.005330:0.010004:0.012950:0.005711:0.012604:0.011699:0.013123:0.005330:0.010016:0.012604:0.006042:0.005330:0.010016:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.010014:0.006523:0.011738:0.013143:0.006523:0.005330
over-express the  somatostatin  receptors :@0.084242:0.534822:0.480505:0.534822:0.480505:0.519066:0.084242:0.519066:0.012604:0.010660:0.012508:0.005792:0.006388:0.012508:0.009236:0.013123:0.005707:0.012508:0.007466:0.007466:0.011969:0.006523:0.011738:0.012508:0.005330:0.006625:0.007466:0.012604:0.018049:0.013143:0.006523:0.012604:0.007466:0.006523:0.013143:0.006523:0.003848:0.011738:0.005330:0.006629:0.005711:0.012508:0.012450:0.012508:0.013123:0.006523:0.012604:0.005792:0.007466:0.005330
(SSTs) on the tumour-cell membrane. They :@0.084242:0.551543:0.480501:0.551543:0.480501:0.535787:0.084242:0.535787:0.007100:0.009583:0.009583:0.007757:0.007466:0.007100:0.005773:0.012604:0.011738:0.005773:0.006523:0.011738:0.012508:0.005759:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.006388:0.012450:0.012508:0.003848:0.003848:0.005759:0.018049:0.012508:0.018049:0.013123:0.005792:0.013143:0.011738:0.012508:0.005330:0.005759:0.008197:0.011738:0.012508:0.010314:0.005330
most commonly arise from the gastro-en-:@0.084242:0.568265:0.475152:0.568265:0.475152:0.552509:0.084242:0.552509:0.018049:0.012604:0.007466:0.006523:0.007052:0.012450:0.012604:0.018049:0.018049:0.012604:0.011726:0.003848:0.010314:0.007062:0.013143:0.005792:0.003848:0.007466:0.012508:0.007062:0.006042:0.005713:0.012604:0.018049:0.007050:0.006523:0.011738:0.012508:0.007050:0.012950:0.013143:0.007466:0.006523:0.005713:0.012604:0.006388:0.012508:0.011728:0.006388
teropancreatic tissues, but can be found :@0.084242:0.584987:0.480470:0.584987:0.480470:0.569231:0.084242:0.569231:0.006523:0.012508:0.005707:0.012604:0.013123:0.013143:0.011738:0.012450:0.005711:0.012508:0.013143:0.006523:0.003848:0.012450:0.007408:0.006523:0.003848:0.007466:0.007466:0.011699:0.012508:0.007466:0.005330:0.007408:0.013123:0.011699:0.006523:0.007408:0.012450:0.013143:0.011738:0.007408:0.013123:0.012508:0.007408:0.006042:0.012604:0.011699:0.011738:0.013181:0.005330
in virtually any organ of the body. Liver :@0.084242:0.601708:0.480482:0.601708:0.480482:0.585952:0.084242:0.585952:0.003848:0.011738:0.009794:0.010660:0.003848:0.005792:0.006523:0.011699:0.013143:0.003848:0.003848:0.010314:0.009794:0.013143:0.011738:0.010314:0.009794:0.012604:0.005792:0.012950:0.013143:0.011738:0.009794:0.012604:0.006042:0.009794:0.006523:0.011738:0.012508:0.009794:0.013123:0.012604:0.013181:0.010314:0.005330:0.009794:0.008890:0.003848:0.010660:0.012508:0.005792:0.005330
is a common  site of  distant metastasis.  :@0.084242:0.618430:0.480481:0.618457:0.480481:0.602702:0.084242:0.602674:0.003848:0.007466:0.010314:0.013143:0.010314:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.005330:0.004966:0.007466:0.003848:0.006523:0.012508:0.010314:0.012604:0.006042:0.005330:0.004974:0.013181:0.003848:0.007466:0.006523:0.013143:0.011738:0.006523:0.010314:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.007466:0.003848:0.007466:0.005330:0.006222:0.102737
2:@0.468934:0.612838:0.475149:0.612838:0.475149:0.603653:0.468934:0.603653:0.006215
NETs may be functional or non-functional. :@0.084242:0.635179:0.480508:0.635179:0.480508:0.619423:0.084242:0.619423:0.014239:0.010314:0.007749:0.007466:0.006119:0.018049:0.013143:0.010314:0.006119:0.013123:0.012508:0.006119:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.006109:0.012604:0.005792:0.006104:0.011738:0.012604:0.011738:0.006388:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.005330:0.005330
Functional  NETs produce  biologically ac-:@0.084242:0.651901:0.475149:0.651901:0.475149:0.636145:0.084242:0.636145:0.009333:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.005330:0.003292:0.014239:0.010314:0.007749:0.007466:0.008640:0.013123:0.005715:0.012604:0.013181:0.011699:0.012450:0.012508:0.005330:0.003292:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.008640:0.013143:0.012450:0.006388
tive substances such as serotonin (as in :@0.084242:0.668622:0.480462:0.668622:0.480462:0.652867:0.084242:0.652867:0.006523:0.003848:0.010660:0.012508:0.010295:0.007466:0.011699:0.013123:0.007466:0.006523:0.013143:0.011738:0.012450:0.012508:0.007466:0.010295:0.007466:0.011699:0.012450:0.011738:0.010295:0.013143:0.007466:0.010295:0.007466:0.012508:0.005715:0.012604:0.006523:0.012604:0.011738:0.003848:0.011738:0.010295:0.007100:0.013143:0.007466:0.010295:0.003848:0.011738:0.005330
carcinoid),  glucagon  (as in  glucagono-:@0.084242:0.685344:0.475151:0.685344:0.475151:0.669588:0.084242:0.669588:0.012450:0.013143:0.005657:0.012450:0.003848:0.011738:0.012604:0.003848:0.013181:0.007100:0.005330:0.005330:0.005802:0.012950:0.003848:0.011699:0.012450:0.013143:0.012950:0.012604:0.011738:0.005330:0.005792:0.007100:0.013143:0.007466:0.011141:0.003848:0.011738:0.005330:0.005800:0.012950:0.003848:0.011699:0.012450:0.013143:0.012950:0.012604:0.011738:0.012586:0.006388
ma) or insulin (as in insulinoma), and so on. :@0.084242:0.702066:0.480443:0.702066:0.480443:0.686310:0.084242:0.686310:0.018049:0.013143:0.007100:0.004811:0.012604:0.005792:0.004811:0.003848:0.011738:0.007466:0.011699:0.003848:0.003848:0.011738:0.004811:0.007100:0.013143:0.007466:0.004811:0.003848:0.011738:0.004811:0.003848:0.011738:0.007466:0.011699:0.003848:0.003848:0.011738:0.012604:0.018049:0.013143:0.007100:0.005330:0.004811:0.013143:0.011738:0.013181:0.004811:0.007466:0.012604:0.004811:0.012604:0.011738:0.005330:0.005330
Due to the biological effects of these se-:@0.084242:0.718787:0.475157:0.718787:0.475157:0.703032:0.084242:0.703032:0.014316:0.011699:0.012508:0.007274:0.006523:0.012604:0.007264:0.006523:0.011738:0.012508:0.007264:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.007274:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.007274:0.012604:0.006042:0.007274:0.006523:0.011738:0.012508:0.007466:0.012508:0.007264:0.007466:0.012508:0.006388
creted substances, functional NETs come :@0.084242:0.735509:0.480464:0.735509:0.480464:0.719753:0.084242:0.719753:0.012450:0.005713:0.012508:0.006523:0.012508:0.013181:0.007524:0.007466:0.011699:0.013123:0.007466:0.006523:0.013143:0.011738:0.012450:0.012508:0.007466:0.005330:0.007524:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.013133:0.003848:0.007524:0.014239:0.010314:0.007749:0.007466:0.007524:0.012450:0.012604:0.018049:0.012508:0.005330
to clinical attention early when the tumour :@0.084242:0.752231:0.480520:0.752231:0.480520:0.736475:0.084242:0.736475:0.006523:0.012604:0.004464:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.004464:0.013143:0.006523:0.006523:0.012508:0.011738:0.006523:0.003848:0.012604:0.011738:0.004464:0.012508:0.013143:0.005792:0.003848:0.010314:0.004464:0.015990:0.011738:0.012508:0.011738:0.004464:0.006523:0.011738:0.012508:0.004464:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330
is still very small and presents a diagnostic :@0.084242:0.768952:0.480481:0.768952:0.480481:0.753197:0.084242:0.753197:0.003848:0.007466:0.006061:0.007466:0.006523:0.003848:0.003848:0.003848:0.006061:0.010660:0.012508:0.005792:0.010314:0.006061:0.007466:0.018049:0.013143:0.003848:0.003848:0.006061:0.013143:0.011738:0.013181:0.006061:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.007466:0.006061:0.013143:0.006061:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.006523:0.003848:0.012450:0.005330
challenge with anatomic imaging.  Non-:@0.084242:0.785674:0.475178:0.785674:0.475178:0.769918:0.084242:0.769918:0.012450:0.011738:0.013143:0.003848:0.003848:0.012508:0.011738:0.012950:0.012508:0.009948:0.015990:0.003848:0.006523:0.011738:0.009948:0.013143:0.011738:0.013143:0.006523:0.012604:0.018049:0.003848:0.012450:0.009948:0.003848:0.018049:0.013143:0.012950:0.003848:0.011738:0.012950:0.005330:0.005330:0.004607:0.014239:0.012604:0.011738:0.006388
functional NETs are diagnosed at a more :@0.084242:0.802396:0.480498:0.802396:0.480498:0.786640:0.084242:0.786640:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.007302:0.014239:0.010314:0.007749:0.007466:0.007312:0.013143:0.005715:0.012508:0.007312:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.012508:0.013181:0.007312:0.013143:0.006523:0.007312:0.013143:0.007312:0.018049:0.012604:0.005709:0.012508:0.005330
advanced stage, often as a result of pres-:@0.084242:0.819117:0.475153:0.819117:0.475153:0.803362:0.084242:0.803362:0.013143:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.005465:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330:0.005455:0.012604:0.006042:0.006523:0.012508:0.011738:0.005449:0.013143:0.007466:0.005465:0.013143:0.005465:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.005465:0.012604:0.006042:0.005455:0.013123:0.005715:0.012508:0.007466:0.006388
sure symptoms from a large tumour bulk or :@0.084242:0.835839:0.480497:0.835839:0.480497:0.820083:0.084242:0.820083:0.007466:0.011699:0.005715:0.012508:0.004718:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.004734:0.006042:0.005711:0.012604:0.018049:0.004718:0.013143:0.004722:0.003848:0.013143:0.005811:0.012950:0.012508:0.004716:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.004707:0.013123:0.011699:0.003848:0.009660:0.004724:0.012604:0.005792:0.005330
its metastasis.:@0.084242:0.852561:0.208875:0.852561:0.208875:0.836805:0.084242:0.836805:0.003848:0.006523:0.007466:0.005330:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.007466:0.003848:0.007466:0.005330
Surgical  excision with curative intent is  :@0.102426:0.869282:0.480481:0.869282:0.480481:0.853527:0.102426:0.853527:0.009583:0.011699:0.005805:0.012950:0.003848:0.012450:0.013143:0.003848:0.005330:0.004033:0.012508:0.009236:0.012450:0.003848:0.007466:0.003848:0.012604:0.011738:0.009352:0.015990:0.003848:0.006523:0.011738:0.009352:0.012450:0.011699:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.009352:0.003848:0.011738:0.006523:0.012508:0.011738:0.006523:0.009352:0.003848:0.007466:0.000000:0.005330
the preferred treatment option in localised  :@0.084242:0.886004:0.480481:0.886004:0.480481:0.870248:0.084242:0.870248:0.006523:0.011738:0.012508:0.004178:0.013123:0.005715:0.012508:0.006042:0.012508:0.005792:0.005705:0.012508:0.013181:0.004183:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.004176:0.012604:0.013123:0.006523:0.003848:0.012604:0.011738:0.004183:0.003848:0.011738:0.004195:0.003848:0.012604:0.012450:0.013143:0.003848:0.003848:0.007466:0.012508:0.013181:0.000000:0.005330
NETs. Somatostatin analogues with octreo- :@0.084242:0.902726:0.480485:0.902726:0.480485:0.886970:0.084242:0.886970:0.014239:0.010314:0.007749:0.007466:0.005330:0.004522:0.009583:0.012604:0.018049:0.013143:0.006523:0.012604:0.007466:0.006523:0.013143:0.006523:0.003848:0.011738:0.004522:0.013143:0.011738:0.013143:0.003848:0.012604:0.012950:0.011699:0.012508:0.007466:0.004522:0.015990:0.003848:0.006523:0.011738:0.004522:0.012604:0.012450:0.006523:0.005705:0.012508:0.012604:0.006388:0.005330
tide or lanreotide are first-line agents in me- :@0.084242:0.919447:0.480475:0.919447:0.480475:0.903692:0.084242:0.903692:0.006523:0.003848:0.013181:0.012508:0.003594:0.012604:0.005792:0.003585:0.003848:0.013143:0.011738:0.005709:0.012508:0.012604:0.006523:0.003848:0.013181:0.012508:0.003587:0.013143:0.005715:0.012508:0.003593:0.004686:0.004686:0.005792:0.007466:0.006523:0.006388:0.003848:0.003848:0.011738:0.012508:0.003589:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.003589:0.003848:0.011738:0.003594:0.018049:0.012508:0.006388:0.005330
tastatic NETs. They provide symptomatic :@0.084242:0.936169:0.480493:0.936169:0.480493:0.920413:0.084242:0.920413:0.006523:0.013143:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.009929:0.014239:0.010314:0.007749:0.007466:0.005330:0.009929:0.008197:0.011738:0.012508:0.010314:0.009929:0.013123:0.005713:0.012604:0.010660:0.003848:0.013181:0.012508:0.009929:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.013143:0.006523:0.003848:0.012450:0.005330
relief in patients with functional NETs and :@0.523642:0.443039:0.919862:0.443039:0.919862:0.427283:0.523642:0.427283:0.005713:0.012508:0.003848:0.003848:0.012508:0.006042:0.007735:0.003848:0.011738:0.007735:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007735:0.015990:0.003848:0.006523:0.011738:0.007735:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011726:0.013143:0.003848:0.007735:0.014239:0.010314:0.007749:0.007466:0.007735:0.013143:0.011738:0.013181:0.005330
may halt progression of  the  disease. :@0.523642:0.459483:0.919903:0.459483:0.919903:0.443727:0.523642:0.443727:0.018049:0.013143:0.010314:0.016722:0.011738:0.013143:0.003848:0.006523:0.016722:0.013123:0.005715:0.012604:0.012950:0.005709:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.016722:0.012604:0.006042:0.005330:0.011376:0.006523:0.011738:0.012508:0.005330:0.011376:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.005330
Chemotherapy offers little benefit in well-:@0.523642:0.475926:0.914544:0.475926:0.914544:0.460171:0.523642:0.460171:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.007125:0.012604:0.006094:0.006042:0.012508:0.005792:0.007466:0.007135:0.003848:0.003848:0.006523:0.006523:0.003848:0.012508:0.007143:0.013123:0.012508:0.011738:0.012508:0.004686:0.004686:0.006523:0.007129:0.003848:0.011738:0.007141:0.015990:0.012508:0.003848:0.003848:0.006388
differentiated NETs as these tumours  are :@0.523642:0.492370:0.919881:0.492370:0.919881:0.476614:0.523642:0.476614:0.013181:0.003848:0.006102:0.006042:0.012508:0.005711:0.012508:0.011738:0.006523:0.003848:0.013143:0.006523:0.012508:0.013181:0.009448:0.014239:0.010314:0.007749:0.007466:0.009448:0.013143:0.007466:0.009448:0.006523:0.011738:0.012508:0.007466:0.012508:0.009448:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.004106:0.013143:0.005715:0.012508:0.005330
slow-growing.:@0.523642:0.508814:0.651065:0.508814:0.651065:0.493058:0.523642:0.493058:0.007466:0.003848:0.012604:0.015990:0.006388:0.012950:0.005715:0.012604:0.015990:0.003848:0.011738:0.012950:0.005330
Peptide receptor radionuclide therapy :@0.541826:0.525258:0.919922:0.525258:0.919922:0.509502:0.541826:0.509502:0.011199:0.012315:0.012931:0.006331:0.003656:0.012989:0.012315:0.011276:0.005521:0.012315:0.012257:0.012315:0.012931:0.006331:0.012411:0.005600:0.011276:0.005600:0.012950:0.012989:0.003656:0.012411:0.011545:0.011507:0.012257:0.003656:0.003656:0.012989:0.012315:0.011276:0.006331:0.011545:0.012315:0.005600:0.012950:0.012931:0.010318:0.005330
(PRRNT) has evolved in recent years to be a :@0.523642:0.541702:0.919897:0.541702:0.919897:0.525946:0.523642:0.525946:0.006908:0.011199:0.011488:0.011488:0.014047:0.008005:0.006908:0.004203:0.011545:0.012950:0.007274:0.004201:0.012315:0.010468:0.012411:0.003656:0.010468:0.012315:0.012989:0.004203:0.003656:0.011545:0.004201:0.005521:0.012315:0.012257:0.012315:0.011545:0.006331:0.004203:0.010122:0.012315:0.012950:0.005600:0.007274:0.004201:0.006331:0.012411:0.004201:0.012931:0.012315:0.004201:0.013146:0.005330
highly effective therapy option in patients :@0.523642:0.558146:0.919887:0.558146:0.919887:0.542390:0.523642:0.542390:0.011545:0.003656:0.012758:0.011545:0.003656:0.010122:0.007281:0.012315:0.005904:0.005850:0.012315:0.012257:0.006331:0.003656:0.010468:0.012315:0.007283:0.006331:0.011545:0.012315:0.005600:0.012950:0.012931:0.010122:0.007283:0.012411:0.012931:0.006331:0.003656:0.012411:0.011545:0.007283:0.003656:0.011545:0.007281:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007470:0.005330
with well differentiated NETs. The SSTs over-:@0.523642:0.574590:0.914580:0.574590:0.914580:0.558834:0.523642:0.558834:0.015798:0.003656:0.006331:0.011545:0.006119:0.015798:0.012315:0.003656:0.003656:0.006119:0.012989:0.003656:0.005905:0.005850:0.012315:0.005521:0.012315:0.011545:0.006331:0.003656:0.012950:0.006331:0.012315:0.012989:0.006119:0.014047:0.010122:0.007558:0.007274:0.005138:0.006119:0.008005:0.011545:0.012315:0.006119:0.009390:0.009390:0.007560:0.007274:0.006119:0.012411:0.010468:0.012315:0.005600:0.006388
expressed on well differentiated NETs are :@0.523642:0.591033:0.919905:0.591033:0.919905:0.575277:0.523642:0.575277:0.012315:0.009044:0.012931:0.005521:0.012315:0.007274:0.007274:0.012315:0.012989:0.008986:0.012411:0.011545:0.008986:0.015798:0.012315:0.003656:0.003656:0.008986:0.012989:0.003656:0.005905:0.005850:0.012315:0.005519:0.012315:0.011545:0.006331:0.003656:0.012950:0.006331:0.012315:0.012989:0.008986:0.014047:0.010122:0.007558:0.007274:0.008986:0.012950:0.005521:0.012506:0.005330
the molecular targets. Theranostic radio- :@0.523642:0.607477:0.919881:0.607477:0.919881:0.591721:0.523642:0.591721:0.006331:0.011545:0.012315:0.010487:0.017857:0.012411:0.003656:0.012315:0.012257:0.011507:0.003656:0.012950:0.005600:0.010487:0.006331:0.012950:0.005613:0.012758:0.012315:0.006331:0.007274:0.005138:0.010487:0.008005:0.011545:0.012315:0.005600:0.012950:0.011545:0.012411:0.007274:0.006331:0.003656:0.012257:0.010487:0.005600:0.012950:0.012989:0.003656:0.012411:0.006356:0.005330
pharmaceuticals used consist of three :@0.523642:0.623921:0.919889:0.623921:0.919889:0.608165:0.523642:0.608165:0.012931:0.011545:0.012950:0.006131:0.017857:0.012950:0.012257:0.012315:0.011507:0.006331:0.003656:0.012257:0.012950:0.003656:0.007274:0.015760:0.011507:0.007274:0.012315:0.012989:0.015760:0.012257:0.012411:0.011545:0.007274:0.003656:0.007274:0.006331:0.015760:0.012411:0.005850:0.015760:0.006331:0.011545:0.005521:0.012315:0.012506:0.005330
parts;  a  somatostatin  analogue,  a  radio-:@0.523642:0.640365:0.914561:0.640365:0.914561:0.624609:0.523642:0.624609:0.012931:0.012950:0.005600:0.006331:0.007274:0.005138:0.005330:0.004320:0.012950:0.005330:0.004320:0.007274:0.012411:0.017857:0.012950:0.006331:0.012411:0.007274:0.006331:0.012950:0.006331:0.003656:0.011545:0.005330:0.004320:0.012950:0.011545:0.012950:0.003656:0.012411:0.012758:0.011507:0.012315:0.005138:0.005330:0.004320:0.012950:0.005330:0.004320:0.005600:0.012950:0.012989:0.003656:0.012411:0.006388
nuclide and a linker molecule connecting :@0.523642:0.656809:0.919935:0.656809:0.919935:0.641053:0.523642:0.641053:0.011545:0.011507:0.012257:0.003656:0.003656:0.012989:0.012315:0.006716:0.012950:0.011545:0.012989:0.006716:0.012950:0.006716:0.003656:0.003656:0.011545:0.009467:0.012315:0.005600:0.006716:0.017857:0.012411:0.003656:0.012315:0.012257:0.011507:0.003656:0.012315:0.006716:0.012257:0.012411:0.011545:0.011545:0.012315:0.012257:0.006331:0.003656:0.011545:0.012946:0.005330
the two. For imaging, Gallium 68 (Ga-68) is :@0.523642:0.673253:0.919868:0.673253:0.919868:0.657497:0.523642:0.657497:0.006331:0.011545:0.012315:0.005877:0.006331:0.015798:0.012411:0.005138:0.005877:0.009140:0.012411:0.005600:0.005879:0.003656:0.017857:0.012950:0.012758:0.003656:0.011545:0.012758:0.005138:0.005879:0.016587:0.012950:0.003656:0.003656:0.003656:0.011507:0.017857:0.005877:0.010468:0.010468:0.005879:0.006908:0.016587:0.012950:0.006196:0.010468:0.010468:0.006908:0.005877:0.003656:0.007470:0.005330
the radionuclide used for positron emission :@0.523642:0.689697:0.919889:0.689697:0.919889:0.673941:0.523642:0.673941:0.006331:0.011545:0.012315:0.005798:0.005600:0.012950:0.012989:0.003656:0.012411:0.011545:0.011507:0.012257:0.003656:0.003656:0.012989:0.012315:0.005798:0.011507:0.007274:0.012315:0.012989:0.005798:0.005850:0.012411:0.005600:0.005800:0.012931:0.012411:0.007274:0.003656:0.006331:0.005521:0.012411:0.011545:0.005798:0.012315:0.017857:0.003656:0.007274:0.007274:0.003656:0.012411:0.011736:0.005330
tomography (PET) imaging, while DOTA :@0.523642:0.706140:0.919910:0.706140:0.919910:0.690384:0.523642:0.690384:0.006331:0.012411:0.017857:0.012411:0.012758:0.005600:0.012950:0.012931:0.011545:0.010122:0.013566:0.006908:0.011199:0.010122:0.008005:0.006908:0.013566:0.003656:0.017857:0.012950:0.012758:0.003656:0.011545:0.012758:0.005138:0.013566:0.015798:0.011545:0.003656:0.003656:0.012315:0.013566:0.014124:0.016529:0.006440:0.014236:0.005330
is a common linker molecule. Ga-68 DO-:@0.523642:0.722584:0.914532:0.722584:0.914532:0.706828:0.523642:0.706828:0.003656:0.007274:0.008601:0.012950:0.008601:0.012257:0.012411:0.017857:0.017857:0.012411:0.011545:0.008601:0.003656:0.003656:0.011545:0.009467:0.012315:0.005600:0.008601:0.017857:0.012411:0.003656:0.012315:0.012257:0.011507:0.003656:0.012315:0.005138:0.008601:0.016587:0.012950:0.006196:0.010468:0.010468:0.008601:0.014124:0.016529:0.006388
TATATE, Ga-68 DOTATOC and Ga-68 DO-:@0.523642:0.739028:0.914517:0.739028:0.914517:0.723272:0.523642:0.723272:0.006440:0.012483:0.006440:0.012483:0.008005:0.010122:0.005138:0.010468:0.016587:0.012950:0.006196:0.010468:0.010468:0.010468:0.014124:0.016529:0.006440:0.012483:0.008005:0.016529:0.015452:0.010468:0.012950:0.011545:0.012989:0.010468:0.016587:0.012950:0.006196:0.010468:0.010468:0.010468:0.014124:0.016529:0.006388
TANOC are the common radiopharma-:@0.523642:0.755472:0.914555:0.755472:0.914555:0.739716:0.523642:0.739716:0.006440:0.014047:0.014047:0.016529:0.015452:0.012681:0.012950:0.005521:0.012315:0.012681:0.006331:0.011545:0.012315:0.012681:0.012257:0.012411:0.017857:0.017857:0.012411:0.011545:0.012681:0.005600:0.012950:0.012989:0.003656:0.012411:0.012931:0.011545:0.012950:0.006131:0.017857:0.012950:0.006388
ceuticals for NETs PET imaging. For therapy, :@0.523642:0.771916:0.919935:0.771916:0.919935:0.756160:0.523642:0.756160:0.012257:0.012315:0.011507:0.006331:0.003656:0.012257:0.012950:0.003656:0.007274:0.005330:0.005850:0.012411:0.005600:0.005330:0.014047:0.010122:0.007560:0.007274:0.005330:0.011199:0.010122:0.008005:0.005330:0.003656:0.017857:0.012950:0.012758:0.003656:0.011545:0.012758:0.005138:0.005330:0.009140:0.012411:0.005600:0.005330:0.006331:0.011545:0.012315:0.005600:0.012950:0.012931:0.010122:0.005328:0.005330
Ga-68 is substituted for a radionuclide that :@0.523642:0.788360:0.919908:0.788360:0.919908:0.772604:0.523642:0.772604:0.016587:0.012950:0.006196:0.010468:0.010468:0.005869:0.003656:0.007274:0.005869:0.007274:0.011507:0.012931:0.007274:0.006331:0.003656:0.006331:0.011507:0.006331:0.012315:0.012989:0.005869:0.005850:0.012411:0.005600:0.005859:0.012950:0.005869:0.005600:0.012950:0.012989:0.003656:0.012411:0.011545:0.011507:0.012257:0.003656:0.003656:0.012989:0.012315:0.005869:0.006331:0.011545:0.012950:0.006521:0.005330
emits energetic ionising radiations, such as :@0.523642:0.804804:0.919918:0.804804:0.919918:0.789048:0.523642:0.789048:0.012315:0.017857:0.003656:0.006331:0.007274:0.006081:0.012315:0.011545:0.012315:0.005615:0.012758:0.012315:0.006331:0.003656:0.012257:0.006081:0.003656:0.012411:0.011545:0.003656:0.007274:0.003656:0.011545:0.012758:0.006081:0.005600:0.012950:0.012989:0.003656:0.012950:0.006331:0.003656:0.012411:0.011545:0.007274:0.005138:0.006081:0.007274:0.011507:0.012257:0.011545:0.006081:0.012950:0.007468:0.005330
beta  particles.  Lutetium  177  (Lu-177)  and :@0.523642:0.821247:0.919856:0.821247:0.919856:0.805491:0.523642:0.805491:0.012931:0.012315:0.006331:0.012950:0.005330:0.003739:0.012931:0.012950:0.005600:0.006331:0.003656:0.012257:0.003656:0.012315:0.007274:0.005138:0.005330:0.003739:0.008698:0.011507:0.006331:0.012315:0.006331:0.003656:0.011507:0.017857:0.005330:0.003741:0.010468:0.010468:0.010468:0.005330:0.003741:0.006908:0.008698:0.011507:0.006196:0.010468:0.010468:0.010468:0.006908:0.005330:0.003739:0.012950:0.011545:0.013181:0.005330
Yttrium 90 (Y-90) are the two most com-:@0.523642:0.837691:0.914588:0.837691:0.914588:0.821935:0.523642:0.821935:0.011199:0.006331:0.006331:0.005600:0.003656:0.011507:0.017857:0.009583:0.010468:0.010468:0.009583:0.006908:0.011199:0.006196:0.010468:0.010468:0.006908:0.009583:0.012950:0.005521:0.012315:0.009583:0.006331:0.011545:0.012315:0.009583:0.006331:0.015798:0.012411:0.009583:0.017857:0.012411:0.007274:0.006331:0.009583:0.012257:0.012411:0.017857:0.006388
monly used beta particle-emitting radionu-:@0.523642:0.854135:0.914551:0.854135:0.914551:0.838379:0.523642:0.838379:0.017857:0.012411:0.011545:0.003656:0.010122:0.004830:0.011507:0.007274:0.012315:0.012989:0.004830:0.012931:0.012315:0.006331:0.012950:0.004830:0.012931:0.012950:0.005600:0.006331:0.003656:0.012257:0.003656:0.012315:0.006196:0.012315:0.017857:0.003656:0.006331:0.006331:0.003656:0.011545:0.012758:0.004830:0.005600:0.012950:0.012989:0.003656:0.012411:0.011545:0.011507:0.006388
clides in PRRNT (see Figure 1).:@0.523642:0.870579:0.789320:0.870579:0.789320:0.854823:0.523642:0.854823:0.012257:0.003656:0.003656:0.012989:0.012315:0.007274:0.005138:0.003656:0.011545:0.005138:0.011199:0.011488:0.011488:0.014047:0.008005:0.005138:0.006908:0.007274:0.012315:0.012315:0.005138:0.009140:0.003656:0.012758:0.011507:0.005521:0.012315:0.005138:0.010468:0.006908:0.005330
PRRNT is indicated in patients with meta- :@0.541826:0.887023:0.919866:0.887023:0.919866:0.871267:0.541826:0.871267:0.011392:0.011680:0.011680:0.014239:0.008197:0.004757:0.003848:0.007466:0.004772:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.012508:0.013181:0.004772:0.003848:0.011738:0.004772:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.004772:0.015990:0.003848:0.006523:0.011738:0.004772:0.018049:0.012508:0.006523:0.013143:0.006388:0.005330
stasised, progressive SST-expressing NETs,  :@0.523642:0.903467:0.919881:0.903467:0.919881:0.887711:0.523642:0.887711:0.007466:0.006523:0.013143:0.007466:0.003848:0.007466:0.012508:0.013181:0.005330:0.011334:0.013123:0.005715:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.003848:0.010660:0.012508:0.011334:0.009583:0.009583:0.008197:0.006388:0.012508:0.009236:0.013123:0.005711:0.012508:0.007466:0.007466:0.003848:0.011738:0.012950:0.011334:0.014239:0.010314:0.007749:0.007466:0.005330:0.000000:0.005330
including gastro-enteropancreatic  and  :@0.523642:0.919910:0.919881:0.919910:0.919881:0.904155:0.523642:0.904155:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.003848:0.011738:0.012950:0.018280:0.012950:0.013143:0.007466:0.006523:0.005711:0.012604:0.006388:0.012508:0.011738:0.006523:0.012508:0.005700:0.012604:0.013123:0.013143:0.011738:0.012450:0.005713:0.012508:0.013143:0.006523:0.003848:0.012450:0.005330:0.012941:0.013143:0.011738:0.013181:0.000000:0.005330
bronchial NETs. :@0.523642:0.936354:0.667606:0.936354:0.667606:0.920598:0.523642:0.920598:0.013123:0.005715:0.012604:0.011738:0.012450:0.011738:0.003848:0.013143:0.003848:0.005330:0.014239:0.010314:0.007747:0.007466:0.005330:0.005330
Figure 1. Ga-DOTATATE PET/CT images of patient with multi-resistant neuro-endocrine tumour :@0.084242:0.096673:0.901668:0.096562:0.901668:0.080172:0.084242:0.080282:0.009756:0.005272:0.011257:0.011218:0.007158:0.010160:0.003887:0.010680:0.005003:0.014718:0.013277:0.010160:0.006196:0.013393:0.013258:0.009159:0.011026:0.009159:0.011026:0.010545:0.010275:0.003887:0.011180:0.010370:0.010545:0.006369:0.011719:0.010545:0.003887:0.005272:0.016548:0.010160:0.011257:0.010160:0.008351:0.003887:0.011103:0.006562:0.003887:0.011507:0.010004:0.007062:0.005272:0.010160:0.011161:0.007062:0.003887:0.014605:0.005272:0.007062:0.011276:0.003887:0.016548:0.011218:0.005292:0.007062:0.005272:0.006196:0.007154:0.010160:0.008351:0.005272:0.008351:0.007062:0.010160:0.011161:0.007062:0.003887:0.011276:0.010160:0.011218:0.007158:0.011411:0.006504:0.010160:0.011276:0.011468:0.011161:0.008678:0.007312:0.005272:0.011276:0.010160:0.003887:0.007062:0.011218:0.016548:0.011103:0.011218:0.007312:0.440150
68 :@0.158632:0.090778:0.173351:0.090778:0.173351:0.081222:0.158632:0.081222:0.006226:0.006226:0.002266
showing good response after fourth therapy with  Lu-DOTATATE. Left panel: before therapy; :@0.084239:0.112001:0.882887:0.111997:0.882887:0.095606:0.084239:0.095610:0.008351:0.011276:0.010930:0.014605:0.005272:0.011276:0.011257:0.003887:0.011257:0.011159:0.011161:0.011468:0.003887:0.007158:0.010160:0.008351:0.011565:0.011103:0.011276:0.008351:0.010160:0.003887:0.010160:0.006848:0.006966:0.010160:0.007312:0.003887:0.006369:0.011103:0.011218:0.007716:0.007062:0.011276:0.003887:0.007062:0.011276:0.010160:0.007100:0.010160:0.011334:0.010064:0.003887:0.014605:0.005272:0.007062:0.011276:0.003887:0.018680:0.009621:0.011218:0.006196:0.013393:0.013258:0.009159:0.011026:0.009159:0.011026:0.010545:0.010122:0.005003:0.003887:0.009662:0.010160:0.006848:0.007062:0.003887:0.011507:0.010160:0.011276:0.010160:0.005292:0.005003:0.003887:0.011565:0.010160:0.006369:0.011103:0.007158:0.010160:0.003887:0.007062:0.011276:0.010160:0.007100:0.010160:0.011334:0.010160:0.005003:0.436482
177:@0.509148:0.106212:0.527826:0.106212:0.527826:0.096656:0.509148:0.096656:0.006226:0.006226:0.006226
right panel: after the fourth therapy with  Lu-DOTATATE:@0.084250:0.127435:0.570526:0.127431:0.570526:0.111040:0.084250:0.111044:0.007312:0.005272:0.011257:0.011161:0.007062:0.003887:0.011507:0.010160:0.011276:0.010160:0.005292:0.005003:0.003887:0.010160:0.006848:0.006966:0.010160:0.007312:0.003887:0.007062:0.011276:0.010160:0.003887:0.006369:0.011103:0.011218:0.007714:0.007062:0.011276:0.003887:0.007062:0.011276:0.010160:0.007100:0.010160:0.011334:0.010064:0.003887:0.014605:0.005272:0.007062:0.011276:0.003887:0.018670:0.009621:0.011218:0.006196:0.013393:0.013258:0.009159:0.011026:0.009159:0.011026:0.010545:0.732782
177:@0.436971:0.121646:0.455649:0.121646:0.455649:0.112090:0.436971:0.112090:0.006226:0.006226:0.006226